Karyopherin abnormalities in neurodegenerative proteinopathies.

Area of Science:

• Neurobiology
• Molecular Biology
• Biochemistry

Background:

• Neurodegenerative proteinopathies involve progressive cell loss due to mislocalized and aggregated proteins.
• Proteins like tau and alpha-synuclein aggregate via liquid-liquid phase transitions, influenced by low-complexity regions.
• Defective nucleocytoplasmic transport and karyopherins are increasingly linked to protein mislocalization in these diseases.

Purpose of the Study:

• To investigate the role of karyopherin abnormalities in neurodegenerative proteinopathies.
• To explore the dual function of karyopherins in nucleocytoplasmic transport and protein folding.
• To identify karyopherin dysfunction as a common pathogenic mechanism and potential therapeutic target.

Main Methods:

• Analysis of karyopherin expression and localization in neurodegenerative disease models.
• Investigating the interaction between karyopherins and aggregation-prone proteins.
• Reviewing existing literature on karyopherin function and therapeutic targeting.

Main Results:

• Karyopherin abnormalities (altered expression, mislocalization, aggregation) are found in various neurodegenerative diseases, including ALS, FTD, Alzheimer's, and Parkinson's.
• Karyopherins act as chaperones, preventing misfolding and aggregation of disease-related proteins.
• Karyopherin dysfunction is both a cause and consequence of proteinopathy, creating a detrimental feedback loop.

Conclusions:

• Karyopherin abnormalities are a central factor in the onset and progression of neurodegenerative proteinopathies.
• Targeting karyopherins, which are already explored for cancer and viral infections, presents a promising therapeutic avenue for neurodegenerative diseases.
• Understanding the role of karyopherins could lead to novel disease-modifying treatments.